LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

Search

Zoetis Inc

Open

SectorGezondheidszorg

80.66 5.37

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

76.43

Max

81.52

Belangrijke statistieken

By Trading Economics

Inkomsten

-2M

601M

Verkoop

-125M

2.3B

K/W

Sectorgemiddelde

12.715

49.888

EPS

1.42

Dividendrendement

2.61

Winstmarge

26.569

Werknemers

14,500

EBITDA

-6M

941M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+59.25% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.61%

2.38%

Volgende Winsten

4 aug 2026

Volgende dividenddatum

1 sep 2026

Volgende Ex Dividend datum

20 jul 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-15B

33B

Vorige openingsprijs

75.29

Vorige sluitingsprijs

80.66

Nieuwssentiment

By Acuity

52%

48%

259 / 344 Rangschikking in Healthcare

Zoetis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 aug 2025, 11:06 UTC

Winsten

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5 aug 2025, 11:06 UTC

Winsten

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5 aug 2025, 11:05 UTC

Winsten

Zoetis 2Q Adj EPS $1.76 >ZTS

Peer Vergelijking

Prijswijziging

Zoetis Inc Prognose

Koersdoel

By TipRanks

59.25% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 123.56 USD  59.25%

Hoogste 150 USD

Laagste 95 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zoetis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

12 ratings

6

Buy

6

Hold

0

Sell

Sentiment

By Acuity

259 / 344 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat